AIM ImmunoTech (AIM) PT Lowered to $22 at Ascendiant Capital
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo lowered the price target on AIM ImmunoTech (NYSE: AIM) to $22.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
